Presentation TCT 2014 TCT 694: Early Outcomes with Direct Flow Medical Versus First-Generation Transcatheter Aortic Valve Devices: A Single-Center, Propensity-Matched Analysis Presenter: Thomas F. Luscher, Gennaro Giustino September 16, 2014
Presentation TCT 2014 TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial Presenter: Thomas F. Luscher, Danny Dvir September 16, 2014
Presentation TCT 2014 TAVR Gulf Experience and a Difficult TAVR Case Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Mohammed Balghith September 16, 2014
Presentation TCT 2014 Treatment of Bio-Prosthetic Valve Deterioration Using The Valve-in-Valve Technique Presenter: Ran Kornowski September 16, 2014
Presentation TCT 2014 Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience Presenter: William Wilson September 16, 2014
Presentation TCT 2014 Trancatheter Aortic Valve Implantation in Patients with Pure Severe Native Aortic Regurgitation: Results after 3 Year of Follow-Up Presenter: Marco Luciano Rossi September 16, 2014
Presentation TCT 2014 The Role of Right Sided Hemodynamic Parameters as Predictors of 30 Day Outcome After Transcatheter Aortic Valve Replacement: The Impact of Right Ventricular Stroke Work Index Presenter: Rajiv Tayal September 16, 2014
Presentation TCT 2014 The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients Presenter: Christopher Meduri September 16, 2014
Presentation TCT 2014 REASONS FOR HOSPITAL READMISSION WITHIN ONE YEAR AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION Presenter: Stefan Stortecky September 16, 2014
Presentation TCT 2014 Predictors For Tissue Embolization During Transcatheter Aortic Valve Implantation Presenter: Ramon Rodriguez-Olivares September 16, 2014
Presentation TCT 2014 N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement Presenter: Ronald Binder September 16, 2014
Presentation TCT 2014 Myocardial Injury Following Transcatheter Aortic Valve Implantation: Insights from Delayed-Enhancement Cardiovascular Magnetic Resonance_ Presenter: Henrique Ribeiro September 16, 2014
Presentation TCT 2014 Long-Term Results Following Transcatheter Aortic Valve Implantation Presenter: Ran Kornowski September 16, 2014
Presentation TCT 2014 Determinants of Left Ventricular Mass Regression in Patients with Severe Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation Presenter: Adaya Weissler-Snir September 16, 2014
Presentation TCT 2014 Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using___ Presenter: Rhanderson Cardoso September 16, 2014
Presentation TCT 2014 Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis Presenter: Luis Nombela-Franco September 16, 2014
Presentation TCT 2014 Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis Presenter: Ran Kornowski September 16, 2014
Presentation TCT 2014 Cardiac Magnetic Resonance Versus Transthoracic Echocardiography for the Assessment and Quantification of Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve___ Presenter: Henrique Ribeiro September 16, 2014
Presentation TCT 2014 Balloon-Expandable Transcatheter Aortic Valves Can Be Effectively And Safely Implanted Transfemorally Without Balloon Valvuloplasty Presenter: Suneil Aggarwal September 16, 2014